Comparative Cardiac Gene Delivery of Adeno‐Associated Virus Serotypes 1–9 reveals that AAV6 Mediates the Most Efficient Transduction in Mouse Heart
- 25 June 2010
- journal article
- research article
- Published by Wiley in Clinical and Translational Science
- Vol. 3 (3), 81-89
- https://doi.org/10.1111/j.1752-8062.2010.00190.x
Abstract
Cardiac gene transfer is an attractive tool for developing novel heart disease treatments. Adeno-associated viral (AAV) vectors are widely used to mediate transgene expression in animal models and are being evaluated for human gene therapy. However, it is not clear which serotype displays the best cardiac tropism. Therefore, we curried out this study to directly compare AAV serotypes 1-9 heart transduction efficiency after indirect intracoronary injection. AAV-cytomegalovirus immediate early enhancer promoter (CMV)-luciferase serotypes 1-9 were injected in the left ventricular cavity of adult mice, after cross-clamping the ascending aorta and pulmonary artery. An imaging system was used to visualize luciferase expression at 3, 7, 21, 70, and 140 days postinjection. Echocardiography was performed to evaluate cardiac function on day 140. At the end of the study, luciferase enzyme activity and genome copies of the different AAV serotypes were assessed in several tissues and potential AAV immunogenicity was evaluated on heart sections by staining for macrophage and lymphocyte antigens. Among AAV serotypes 1-9, AAV6 showed the best capability of achieving high transduction levels in the myocardium in a tissue-specific manner, whereas the other serotypes had less cardiac transduction and more extracardiac expression, especially in the liver. Importantly, none of the serotypes tested with this marker gene affected cardiac function nor was associated with inflammation.Keywords
This publication has 44 references indexed in Scilit:
- Myocardial Adeno-Associated Virus Serotype 6–βARKct Gene Therapy Improves Cardiac Function and Normalizes the Neurohormonal Axis in Chronic Heart FailureCirculation, 2009
- Efficiency of eight different AAV serotypes in transducing rat myocardium in vivoGene Therapy, 2007
- Recombinant Adeno-Associated Virus Serotype 9 Leads to Preferential Cardiac Transduction In VivoCirculation Research, 2006
- Robust systemic transduction with AAV9 vectors in mice: efficient global cardiac gene transfer superior to that of AAV8Molecular Therapy, 2006
- AAV Serotype-1 mediates early onset of gene expression in mouse hearts and results in better therapeutic effectGene Therapy, 2006
- One year transgene expression with adeno-associated virus cardiac gene transferInternational Journal of Cardiology, 2005
- Differential Myocardial Gene Delivery by Recombinant Serotype-Specific Adeno-associated Viral VectorsMolecular Therapy, 2004
- Indirect intracoronary delivery of adenovirus encoding adenylyl cyclase increases left ventricular contractile function in miceAmerican Journal of Physiology-Heart and Circulatory Physiology, 2004
- In vivo high-efficiency transcoronary gene delivery and Cre–LoxP gene switching in the adult mouse heartGene Therapy, 2003
- Myocardial Regeneration Therapy for Heart FailureCirculation, 2002